ANNA DAVIDSON: Open Payments
NPI 1215633987 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 101 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $1,867
Food & beverage: $1,677Education: $190
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $390 |
| Teva Pharmaceuticals USA, Inc. | 12 | $341 |
| Alkermes, Inc. | 23 | $251 |
| Neurocrine BioSciences, Inc. | 17 | $232 |
| E.R. Squibb & Sons, L.L.C. | 5 | $189 |
| Lundbeck LLC | 10 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $149 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: ARISTADA, INGREZZA, HETLIOZ, COBENFY, FANAPT, CAPLYTA, ABILIFY MAINTENA, UZEDY.
Industry payments across KY — which companies pay providers there.
